Ageing of the Haematopoietic Stem Cell Compartment and Clonal Selection
DOI:
https://doi.org/10.5281/zenodo.22274855Keywords:
Haematopoietic stem cells; Clonal haematopoiesis; Ageing; Clonal selection; Somatic mutationAbstract
Background: Ageing of the haematopoietic stem cell compartment is described as declining cell function, largely in mice, and as
clonal selection measured in human blood.
Objective: To separate the evidence by species and by driver gene, and to ask what each body of work supports clinically.
Methods: Narrative review of population cohorts, clonal phylogenies, transplantation series and mouse experiments.
Findings: In 17,182 persons, clonal haematopoiesis rose from 5.6% at 60-69 years to 18.4% at 90 years and above. Growth rates
differed by driver, from about 5% per year for DNMT3A to over 50% for SRSF2 P95H among 385 individuals. In 10 subjects, 30-60%
of haematopoiesis over 75 years derived from 12-18 clones, a collapse that aged mice did not display.
Conclusions: The evidence supports driver-specific rather than pooled risk statements and labelling rejuvenation results as
mouse work; it does not show that oligoclonal haematopoiesis is typical after 70.
References
de Haan, G., Lazare, S.S. (2018) Aging of hematopoietic stem cells. Blood, 131(5): 479-487.
Jaiswal, S., Ebert, B.L. (2019) Clonal hematopoiesis in human aging and disease. Science, 366(6465): eaan4673.
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., et al. (2014) Age-related clonal hematopoiesis associated with adverse outcomes. New England Journal of Medicine, 371(26): 2488-2498.
Steensma, D.P., Bejar, R., Jaiswal, S., Lindsley, R.C., Sekeres, M.A., Hasserjian, R.P., et al. (2015) Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood, 126(1): 9-16.
Wong, C.K., McDonald, A., Buttigieg, M.M., Rauh, M.J. (2026) CHIP ahoy: charting a decade of discovery in clonal hematopoiesis. Haematologica, 111(2): 457-469.
Genovese, G., Kahler, A.K., Handsaker, R.E., Lindberg, J., Rose, S.A., Bakhoum, S.F., et al. (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. New England Journal of Medicine, 371(26): 2477-2487.
Xie, M., Lu, C., Wang, J., McLellan, M.D., Johnson, K., Wendl, M.C., et al. (2014) Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nature Medicine, 20(12): 1472-1478.
Zink, F., Stacey, S.N., Norddahl, G.L., Frigge, M.L., Magnusson, O.T., Jonsdottir, I., et al. (2017) Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood, 130(6): 742-752.
Bick, A.G., Weinstock, J.S., Nandakumar, S.K., Fulco, C.P., Bao, E.L., Zekavat, S.M., et al. (2020) Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature, 586(7831): 763-768.
Kessler, M.D., Damask, A., O'Keeffe, S., Banerjee, N., Li, D., Watanabe, K., et al. (2022) Common and rare variant associations with clonal haematopoiesis phenotypes. Nature, 612(7939): 301-309.
Fabre, M.A., de Almeida, J.G., Fiorillo, E., Mitchell, E., Damaskou, A., Rak, J., et al. (2022) The longitudinal dynamics and natural history of clonal haematopoiesis. Nature, 606(7913): 335-342.
Robertson, N.A., Latorre-Crespo, E., Terradas-Terradas, M., Lemos-Portela, J., Purcell, A.C., Livesey, B.J., et al. (2022) Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects. Nature Medicine, 28(7): 1439-1446.
Watson, C.J., Papula, A.L., Poon, G.Y.P., Wong, W.H., Young, A.L., Druley, T.E., et al. (2020) The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science, 367(6485): 1449-1454.
Desai, P., Mencia-Trinchant, N., Savenkov, O., Simon, M.S., Cheang, G., Lee, S., et al. (2018) Somatic mutations precede acute myeloid leukemia years before diagnosis. Nature Medicine, 24(7): 1015-1023.
Abelson, S., Collord, G., Ng, S.W.K., Weissbrod, O., Mendelson Cohen, N., Niemeyer, E., et al. (2018) Prediction of acute myeloid leukaemia risk in healthy individuals. Nature, 559(7714): 400-404.
Rossi, D.J., Bryder, D., Zahn, J.M., Ahlenius, H., Sonu, R., Wagers, A.J., et al. (2005) Cell intrinsic alterations underlie hematopoietic stem cell aging. Proceedings of the National Academy of Sciences, 102(26): 9194-9199.
Beerman, I., Bhattacharya, D., Zandi, S., Sigvardsson, M., Weissman, I.L., Bryder, D., et al. (2010) Functionally distinct hematopoietic stem cells modulate hematopoietic lineage potential during aging by a mechanism of clonal expansion. Proceedings of the National Academy of Sciences, 107(12): 5465-5470.
Grover, A., Sanjuan-Pla, A., Thongjuea, S., Carrelha, J., Giustacchini, A., Gambardella, A., et al. (2016) Single-cell RNA sequencing reveals molecular and functional platelet bias of aged haematopoietic stem cells. Nature Communications, 7: 11075.
Caiado, F., Pietras, E.M., Manz, M.G. (2021) Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. Journal of Experimental Medicine, 218(7): e20201541.
Ross, J.B., Myers, L.M., Noh, J.J., Collins, M.M., Carmody, A.B., Messer, R.J., et al. (2024) Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature, 628(8006): 162-170.
Dorshkind, K., Hofer, T., Montecino-Rodriguez, E., Pioli, P.D., Rodewald, H.R. (2020) Do haematopoietic stem cells age? Nature Reviews Immunology, 20(3): 196-202.
Pang, W.W., Price, E.A., Sahoo, D., Beerman, I., Maloney, W.J., Rossi, D.J., et al. (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proceedings of the National Academy of Sciences, 108(50): 20012-20017.
Fuster, J.J., MacLauchlan, S., Zuriaga, M.A., Polackal, M.N., Ostriker, A.C., Chakraborty, R., et al. (2017) Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science, 355(6327): 842-847.
Jaiswal, S., Natarajan, P., Silver, A.J., Gibson, C.J., Bick, A.G., Shvartz, E., et al. (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. New England Journal of Medicine, 377(2): 111-121.
Mitchell, E., Spencer Chapman, M., Williams, N., Dawson, K.J., Mende, N., Calderbank, E.F., et al. (2022) Clonal dynamics of haematopoiesis across the human lifespan. Nature, 606(7913): 343-350.
Lee-Six, H., Obro, N.F., Shepherd, M., Grossmann, S., Dawson, K.J., Belmonte, M., et al. (2018) Population dynamics of normal human blood inferred from somatic mutations. Nature, 561(7724): 473-478.
Weng, C., Yu, F., Yang, D., Poeschla, M., Liggett, L.A., Jones, M.G., et al. (2024) Deciphering cell states and genealogies of human haematopoiesis. Nature, 627(8003): 389-398.
Kapadia, C.D., Williams, N., Dawson, K.J., Watson, C.J., Yousefzadeh, M.J., Le, D.T., et al. (2025) Clonal dynamics and somatic evolution of haematopoiesis in mouse. Nature, 641(8063): 681-689.
Kollman, C., Spellman, S.R., Zhang, M.J., Hassebroek, A., Anasetti, C., Antin, J.H., et al. (2016) The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood, 127(2): 260-267.
Frick, M., Chan, W., Arends, C.M., Hablesreiter, R., Halik, A., Heuser, M., et al. (2019) Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 37(5): 375-385.
Gibson, C.J., Kim, H.T., Zhao, L., Murdock, H.M., Hambley, B., Ogata, A., et al. (2022) Donor clonal hematopoiesis and recipient outcomes after transplantation. Journal of Clinical Oncology, 40(2): 189-201.
Boettcher, S., Wilk, C.M., Singer, J., Beier, F., Burcklen, E., Beisel, C., et al. (2020) Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood, 135(18): 1548-1559.
Spencer Chapman, M., Wilk, C.M., Boettcher, S., Mitchell, E., Dawson, K.J., Williams, N., et al. (2024) Clonal dynamics after allogeneic haematopoietic cell transplantation. Nature, 635(8040): 926-934.
Gibson, C.J., Lindsley, R.C., Tchekmedyian, V., Mar, B.G., Shi, J., Jaiswal, S., et al. (2017) Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. Journal of Clinical Oncology, 35(14): 1598-1605.
